BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezhilarasan D, Evraerts J, Brice S, Buc-Calderon P, Karthikeyan S, Sokal E, Najimi M. Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells. J Clin Exp Hepatol 2016;6:167-74. [PMID: 27746612 DOI: 10.1016/j.jceh.2016.01.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Malaviya PB, Shukal DK, Sharma T, Vasavada AR, Johar Sr K. Silibinin suppresses TGFβ2-induced lens epithelial cell migration and epithelial–mesenchymal transition. J Biosci 2022;47. [DOI: 10.1007/s12038-022-00286-3] [Reference Citation Analysis]
2 Ezhilarasan D, Elumalai P, Anandan B, Muralidharan A. Role of Stem Cells and Reactive Oxygen Species in Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_103] [Reference Citation Analysis]
3 Ezhilarasan D, Elumalai P, Anandan B, Muralidharan A. Role of Stem Cells and Reactive Oxygen Species in Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_103-1] [Reference Citation Analysis]
4 Ezhilararasan D, Lakshmi T, Raut B, S VK. Novel Nano-Based Drug Delivery Systems Targeting Hepatic Stellate Cells in the Fibrotic Liver. Journal of Nanomaterials 2021;2021:1-9. [DOI: 10.1155/2021/4674046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Ezhilarasan D. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. J Cell Physiol 2021. [PMID: 34514599 DOI: 10.1002/jcp.30582] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
6 Ezhilarasan D. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Toxicology 2021;458:152840. [PMID: 34175381 DOI: 10.1016/j.tox.2021.152840] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
7 Ezhilarasan D. Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives. Eur J Pharmacol 2021;893:173832. [PMID: 33359144 DOI: 10.1016/j.ejphar.2020.173832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sorrenti V, Vanella L, Platania CBM, Greish K, Bucolo C, Pittalà V, Salerno L. Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure. Int J Mol Sci 2020;21:E9541. [PMID: 33333908 DOI: 10.3390/ijms21249541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ge H, Wang A, Su Y, Yu C, Gao L, Li Y. Ameliorative effects of Qingganjiuwei powder, a traditional Mongolian medicine, against CCl4-induced liver fibrosis in rats. J Ethnopharmacol 2021;264:113226. [PMID: 32829054 DOI: 10.1016/j.jep.2020.113226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Ezhilarasan D. Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells. Exp Biol Med (Maywood) 2020;245:1504-12. [PMID: 32791849 DOI: 10.1177/1535370220949148] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
11 Murali Iyangar R, Devaraj E. Silibinin Triggers the Mitochondrial Pathway of Apoptosis in Human Oral Squamous Carcinoma Cells. Asian Pac J Cancer Prev 2020;21:1877-82. [PMID: 32711410 DOI: 10.31557/APJCP.2020.21.7.1877] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yang HX, Shang Y, Jin Q, Wu YL, Liu J, Qiao CY, Zhan ZY, Ye H, Nan JX, Lian LH. Gentiopicroside Ameliorates the Progression from Hepatic Steatosis to Fibrosis Induced by Chronic Alcohol Intake. Biomol Ther (Seoul) 2020;28:320-7. [PMID: 32248671 DOI: 10.4062/biomolther.2020.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ezhilarasan D, Rajeshkumar S, Lakshmi T. The Role of Oxidative Stress in Chronic Liver Diseases. In: Maurya PK, Dua K, editors. Role of Oxidative Stress in Pathophysiology of Diseases. Singapore: Springer; 2020. pp. 13-25. [DOI: 10.1007/978-981-15-1568-2_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Goh ZH, Tee JK, Ho HK. An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage. Int J Mol Sci 2020;21:E3714. [PMID: 32466226 DOI: 10.3390/ijms21103714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Silva CM, Ferrari GD, Alberici LC, Malaspina O, Moraes KCM. Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism. Mol Cell Biochem 2020;468:129-42. [PMID: 32185674 DOI: 10.1007/s11010-020-03717-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Devaraj E, Roy A, Royapuram Veeraragavan G, Magesh A, Varikalam Sleeba A, Arivarasu L, Marimuthu Parasuraman B. β-Sitosterol attenuates carbon tetrachloride-induced oxidative stress and chronic liver injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1067-75. [PMID: 31930431 DOI: 10.1007/s00210-020-01810-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
17 Devaraj E, Rajeshkumar S. Nanomedicine for Hepatic Fibrosis. Nanoparticles and their Biomedical Applications 2020. [DOI: 10.1007/978-981-15-0391-7_2] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Ezhilarasan D. Lead compounds with the potentials for the treatment of chronic liver diseases. Phytochemicals as Lead Compounds for New Drug Discovery 2020. [DOI: 10.1016/b978-0-12-817890-4.00012-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Goh Z, Tee JK, Ho HK. An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage.. [DOI: 10.1101/815241] [Reference Citation Analysis]
20 Zhang AH, Jiang N, Wang XQ, Tan RX. Galewone, an Anti-Fibrotic Polyketide from Daldinia eschscholzii with an Undescribed Carbon Skeleton. Sci Rep 2019;9:14316. [PMID: 31586120 DOI: 10.1038/s41598-019-50868-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Ezhilarasan D. Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective. Arab J Gastroenterol 2018;19:56-64. [PMID: 29853428 DOI: 10.1016/j.ajg.2018.03.002] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 15.5] [Reference Citation Analysis]
22 Hayashi K, Maruhashi T, Sakamoto W, Yogo T. Organic-Inorganic Hybrid Hollow Nanoparticles Suppress Oxidative Stress and Repair Damaged Tissues for Treatment of Hepatic Fibrosis. Adv Funct Mater 2018;28:1706332. [DOI: 10.1002/adfm.201706332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Gulfishan M, Afzal M, Kazmi I, Quazi AM, Bhat TA, Jahan A. Mechanism of Action of Anticancer Herbal Medicines. Anticancer Plants: Mechanisms and Molecular Interactions 2018. [DOI: 10.1007/978-981-10-8417-1_14] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Salomone F, Barbagallo I, Godos J, Lembo V, Currenti W, Cinà D, Avola R, D'Orazio N, Morisco F, Galvano F, Li Volti G. Silibinin Restores NAD⁺ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver. Nutrients 2017;9:E1086. [PMID: 28973994 DOI: 10.3390/nu9101086] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 10.6] [Reference Citation Analysis]
25 Mann A, Pelz T, Rennert K, Mosig A, Decker M, Lupp A. Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance. Hum Cell 2017;30:267-78. [PMID: 28527127 DOI: 10.1007/s13577-017-0175-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]